United States· US:65841-663_7426aa35-2cba-4a73-b80f-d044bfe22177
Dipyridamole
A dipyridamole product containing dipyridamole, registered in United States by Zydus Lifesciences Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Dipyridamole is registered in 11 of 19 countries.
Countries holding a registration under ATC B01AC07 (dipyridamole), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Dipyridamole · ATC B01AC07
11 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DIPYRIDAMOLE
- Manufacturer
- Zydus Lifesciences Limited
- Country
- United States (US)
- ATC code
- B01AC07
- ATC class
- Dipyridamole
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 8
- ndc116584166301100 TABLET, FILM COATED in 1 BOTTLE (65841-663-01)
- ndc116584166305500 TABLET, FILM COATED in 1 BOTTLE (65841-663-05)
- ndc1165841663101000 TABLET, FILM COATED in 1 BOTTLE (65841-663-10)
- ndc11658416637710 BLISTER PACK in 1 CARTON (65841-663-77) / 10 TABLET, FILM COATED in 1 BLISTER PACK
- ndc1165841-663-01
- ndc1165841-663-05
- ndc1165841-663-10
- ndc1165841-663-77
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
352 interactions on record for dipyridamole.
Graded by severity as the source publishes them — 47 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dipyridamole · interactions on record
352 records
- 47 severe
- 93 moderate
- 5 minor
- 207 info
Most severe, free to view
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
- DanaparoidB01AB09severe
- TinzaparinB01AB10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dipyridamole in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAttia 200mg modified-release capsulesDr Reddy's Laboratories (UK) Ltd
- FinlandAtrombinOy Leiras Finland Ab
- BelgiumDipyridamole EG 150 mgEG
- NorwayAponovaAlternova A/S
- NetherlandsDipyridamol Glenmark 200 mg, harde capsules met gereguleerde afgifteGlenmark Arzneimittel GmbH
- CanadaDIPYRIDAMOLE INJECTION, USPFRESENIUS KABI CANADA LTD
- SwedenDipyridamol Alternova 200 mg Depotkapsel, hårdAlternova A/S
- FrancePERSANTINE 10 mg/2 mL, solution injectable, ampouleGLENWOOD GMBH PHARMAZEUTISCHE ERZEUGNISSE
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Persantin
- Bulgaria · Антистенокардин, Биокардин
- Cyprus · Perazodin, Persantin
- Denmark · Dipyridamol Alternova, Dipyridamol Strides
- Spain · Persantin
- Finland · Persantin
- France · Persantine
- United Kingdom (Northern Ireland) · Attia, Dipyridamole Dr. Reddy’s
- Greece · Persantin
- Croatia · Persantin
- Ireland · Pyranistole
- Iceland · Persantin
- Italy · Corosan, Persantin
- Malta · Perazodin
- Netherlands · Dipyridamol Glenmark, Dipyridamol Sandoz
- Norway · Aponova, Dipyridamol Glenmark
- Portugal · Dipiridamol Labesfal, Persantin
- Sweden · Dipyridamol Alternova, Pyranistole
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9e328b9c-0e45-44db-9556-26675790fa84 GET /v1/drugs/9e328b9c-0e45-44db-9556-26675790fa84?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50",
"substance": "DIPYRIDAMOLE",
"productndc": "65841-663",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA040874",
"marketing_category": "ANDA"
}See everything about dipyridamole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.